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ABSTRACT
The laboratory workload, microbiological techniques and aetiology of catheter-related infections in
European hospitals are mostly unknown. The present study (ESGNI-005) comprised a 1-day (22 October
2001), laboratory-based, point-prevalence survey based on a questionnaire completed by microbiology
laboratories in European (European Union (EU) and non-EU) hospitals. Also included were questions
requesting retrospective information for the year 2000. In total, 151 hospitals from 26 European countries
participated, of which 78.1% were teaching institutions. Overall, the estimated population served by
these institutions was 121 363 800, and the estimated number of admissions during 2000 was 6 712 050.
The total number of catheter tips processed during 2000 was 142 727, or 21 ⁄ 1000 admissions, of which
23.7% were considered to be positive in the institutions using semiquantitative or quantitative
techniques. Overall, EU centres received significantly more catheter tip samples ⁄ 1000 admissions and
had a significantly higher rate of ‘positivity’ (p < 0.0001) than non-EU centres. Of the institutions
surveyed, 11.4% (7.2% in EU countries and 23.7% in non-EU countries; p 0.04) used only qualitative
techniques for catheter tip sample processing. On the day of the study, 167 microorganisms were
recovered from significant catheter tip cultures (122 patients), of which Gram-positive bacteria
represented 70.7%, Gram-negative bacteria 22.2%, and yeasts 7.2%. The five most common microor-
ganisms were coagulase-negative staphylococci, Staphylococcus aureus, Candida spp., Enterococcus spp.
and Pseudomonas spp. Overall, 19% of catheter tip cultures were polymicrobial. In the case of S. aureus,
40% of isolates were resistant to oxacillin, as were 63.4% of coagulase-negative staphylococcus isolates.
Of 37 Gram-negative isolates, 35% were resistant to cefotaxime, 31% to ceftazidime, and 27% to
ciprofloxacin. Imipenem and cefepime had the lowest reported rates of resistance (11%).
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INTRODUCTION
Intravenous catheter-related infections (IV-CRIs)
are common nosocomial infections, which are
currently responsible for > 60% of nosocomial
bacteraemic episodes in European hospitals [1].
Culture of catheter tips with semiquantitative or
quantitative methods is currently the standard
microbiological test for the diagnosis of catheter
colonisation and is an essential part of the
diagnosis of catheter-related bloodstream infec-
tions [2]. The techniques used to diagnose cath-
eter colonisation in European microbiology
laboratories have not been clearly defined and
the corresponding workload is not known.
The aim of this study by the ESCMID Study
Group on Nosocomial Infections (ESGNI) was to
obtain general information on the microbiology
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workload and techniques used for IV-CRI diag-
nosis in Europe, as well as the aetiology and
antimicrobial susceptibility patterns of pathogens
causing intravenous catheter colonisation
(IV-CC). The clinical aspects of intravascular
catheter-related bloodstream infection will be
considered separately.
MATERIALS AND METHODS
The present study (ESGNI-005) was a 1-day (22 October 2001),
laboratory-based, point-prevalence study based on a question-
naire sent to the microbiology laboratories of every European
hospital with one or more ESGNI members (c. 400 invitations
to participate). The questionnaire also included a request for
information on the results for the year 2000 in the participating
laboratories.
The questionnaire requested information on the population
served by the hospital, total number of beds, total number of
admissions, total number of catheter tips sent to microbiology
laboratories, and whether a qualitative, semiquantitative or
quantitative technique was used for processing. Also reques-
ted was information on the total number of sterile samples and
total number of significant positive samples (‡ 15 CFU ⁄mL of
any semiquantitative culture, or any quantitative culture
yielding ‡ 103 CFU) processed during the year 2000. Further-
more, information on the use of indirect methods of assessing
catheter tip colonisation was requested (e.g., comparative
quantitative blood cultures, skin and hub semiquantitative
cultures, differential time to growth between blood cultures
taken from peripheral veins and catheters).
For each episode of IV-CC on the day of study, information
was requested regarding the microorganisms present and their
antibiotic susceptibility profile, regardless of the laboratory
method used for detection. The list of antimicrobial agents
studied included: penicillin, ampicillin, ticarcillin, amoxycil-
lin–clavulanate, oxacillin, cefazolin, cefuroxime, cefotaxime,
ceftazidime, cefepime, imipenem, aztreonam, co-trimoxazole,
ciprofloxacin, levofloxacin, gentamicin, tobramycin, amika-
cin, streptomycin, rifampicin, erythromycin, clindamycin,
vancomycin, tetracycline and chloramphenicol.
Definitions
IV-CC was defined as any semiquantitative culture yielding
‡ 15 CFU, or any quantitative culture yielding ‡ 103 CFU of
bacteria or fungi. Any colony counts below these levels were
considered to be negative. Data from institutions using
qualitative techniques for catheter tip processing were not
included in the study.
Data analysis
Discrete variables were expressed as percentages, and con-
tinuous variables as the mean and standard deviation when
normally distributed, or as the median and interquartile range
if their distribution was not normal. For discrete variables with
missing values, percentages were calculated from the total of
valid cases whenever missing values did not exceed 20% (in
these instances, the variable was excluded from the analysis).
Student’s unpaired t-test was used to compare continuous
variables, the Mann–Whitney U-test to compare continuous
variables not normally distributed, and the chi-square or
Fisher exact test to compare proportions. All statistical tests
were two-tailed.
RESULTS
In total, 151 hospitals from 26 countries partici-
pated in the study (Table 1), comprising 111
hospitals from 12 European Union (EU) countries
and 40 hospitals from 14 non-EU countries.
Laboratory workload of IV-CC during 2000
Of the 151 participating institutions, 78.1% and
21.9%, respectively, were teaching and non-teach-
ing institutions. Hospital sizes varied from < 500
beds (34%), to 500–1000 beds (40.4%) and > 1000
beds (25.2%). Overall, the estimated population
served by these institutions was 121 363 800, and
the number of estimated admissions during 2000
was 6 712 050.
Results regarding the microbiology workload
in 2000 are shown in Table 2. The total number of
catheter tips processed during 2000 was 142 727,
or 21 ⁄ 1000 admissions, of which 23.7% were
considered to be positive in the institutions using
semiquantitative or quantitative techniques.
Table 1. Distribution of participating hospitals (n = 151)
Country
No. of participating
hospitals (%) Country
No. of participating
hospitals (%)
Austria 3 (2) Malta 1 (0.7)
Belgium 10 (6.6) The Netherlands 2 (1.3)
Bosnia-Herzegovina 2 (1.3) Norway 1 (0.7)
Croatia 3 (2) Poland 2 (1.3)
Czech Republic 5 (3.3) Portugal 1 (0.7)
Denmark 1 (0.7) Romania 1 (0.7)
France 11 (7.3) Slovak Republic 4 (2.6)
Germany 12 (7.9) Slovenia 2 (1.3)
Greece 14 (9.3) Spain 32 (21.2)
Hungary 1 (0.7) Sweden 1 (0.7)
Italy 17 (11.3) Switzerland 3 (2)
Israel 1 (0.7) Turkey 13 (8.6)
Lithuania 1 (0.7) UK 7 (4.6)
Table 2. Microbiology workload associated with catheter
tip samples in the year 2000
EU countries
(n = 111)
Non-EU
countries
(n = 40)
Total
(n = 151)
Total catheter tip samples 108 243 34 484 142 727
Total no. of admissions 4 263 850 2 448 197 6 712 047
Catheter tip samples ⁄ 1000
admissions yeara
25 14 21
Positive samples (%) 28 502 (26.3%)a 5391 (15.6%) 33 893 (23.7%)
ap < 0.0001.
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Overall, EU centres received significantly more
catheter tip samples ⁄ 1000 admissions, and
had a significantly higher rate of ‘positivity’
(p < 0.0001) than non-EU centres.
Diagnostic techniques used in different
institutions
Of all the institutions surveyed, 11.4% (7.2% in
EU countries and 23.7% in non-EU countries;
p 0.04) used only qualitative techniques to process
catheter tip samples. Most (63.8%) institutions
processed these samples using semiquantitative
techniques, with no significant differences
between EU and non-EU countries. Quantitative
techniques were used in 24.8% of microbiology
laboratories (27.9% in EU countries vs. 15.8% in
non-EU countries; p 0.07) (Table 3). In 68.5% of
the participating institutions, an indirect method
of assessing catheter colonisation, e.g., comparat-
ive quantitative blood culture, infusate culture,
internal brushing, and skin or hub culture, was
used. These methods were used most frequently
in EU countries (75.7% vs. 47.4%; p 0.02).
Microbiology results on the study day
Data regarding microbiology workload obtained
on the day of the study differed only slightly from
the questionnaire data relating to the year 2000.
On the day of the study, 676 catheter tip samples
were cultured in 151 institutions. Assuming a
similar number of admissions in the year 2001, the
estimated number of catheter tip samples during
the day-prevalence study was 36.8 ⁄ 1000 admis-
sions. According to the criteria of each individual
laboratory, 168 (25%) samples were reported as
positive (Table 4).
It was possible to collect information for 122
positive catheter tip samples, of which 94 were
from EU countries and 28 from non-EU countries.
These samples were taken from patients in inten-
sive care units (41%), surgical services (25.4%)
and general medical services (23.8%).
The number of microorganisms isolated on the
day of the study from significant catheter tip
cultures was 168 (Table 5). Overall, 19% of
cultures were polymicrobial. Gram-positive bac-
teria comprised 70.7% of all isolates, and Gram-
negative bacteria 22.2%. Yeasts were isolated
from 7.2% of catheter tip samples. The five
organisms isolated most commonly were, in
decreasing order: coagulase-negative staphylo-
cocci, Staphylococcus aureus, Candida spp., Entero-
coccus spp. and Pseudomonas spp. The organisms
isolated were similar in both groups of hospitals
(EU and non-EU), with the single exception of
S. aureus, which was isolated more frequently in
non-EU countries (34.3% vs. 6.1%; p < 0.0001).
While Candida was the second most frequently
isolated microorganism in catheter tips in EU
countries (9.1%), laboratories from non-EU coun-
tries did not report any Candida isolates; however,
this difference did not reach statistical signifi-
cance (p 0.2).
Resistance patterns of the most frequent isolates
Table 6 lists the antibiotic resistance data for
organisms isolated from catheter tips in the
different centres. The sensitivity assays were not
performed in a central laboratory, and local
susceptibility testing results were taken at face
value. In the case of S. aureus, 40% of isolates were
resistant to oxacillin, as were 63.4% of coagulase-
negative staphylococcus isolates. Of the 118
Gram-positive isolates from catheter tips in Eur-
ope, 51.5% were oxacillin-resistant, but vancomy-
cin was reported to be active against all but two
single isolates (coagulase-negative staphylococcus
and E. faecalis). Of the 37 Gram-negative organ-
isms isolated, only 65% were susceptible to
cefotaxime, and only 69% to ceftazidime. Ciprofl-
oxacin resistance was reported for 27% of these
isolates, with imipenem and cefepime having the
lowest reported rates of resistance (11%).
Imipenem-resistant Gram-negative organisms
Table 3. Techniques used for the diagnosis of catheter tip
infection
EU
countries
(n = 111)
Non-EU
countries
(n = 40)
Total
(n = 151)
Only qualitative techniquesa 7.2% 23.7% 11.4%
Semiquantitative or quantitative techniques 9.9% 10.5% 10%
Only semiquantitative techniques 64.9% 60.5% 63.8%
Only quantitative techniques 18% 5.3% 14.8%
ap 0.04.
Table 4. Data for catheter tip samples obtained on the
study day (22 October 2001)
EU countries
(n = 111)
Non-EU countries
(n = 40)
Total
(n = 151)
Total catheter tip samples 506 170 676
Total positive samples 132 (26%) 36 (21%) 168 (25%)
840 Clinical Microbiology and Infection, Volume 10 Number 9, September 2004
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 838–842
comprised three Acinetobacter isolates and one
Pseudomonas isolate.
DISCUSSION
Most literature on clinical microbiology, infec-
tious diseases and laboratory medicine gives no
insight into the workload generated by catheter
tip sampling in microbiology laboratories. The
present data, obtained from 151 hospitals in
Europe, show that 21 catheter tip cultures were
processed ⁄ 1000 admissions in 2000, with a signi-
ficant difference between the workloads in EU
and non-EU hospitals. EU hospitals processed
more samples each year, with a higher rate of
positivity, which could partly reflect more inva-
sive procedures in EU countries, with a parallel
higher use of central intravenous lines. It should
be noted that new guidelines discourage routine
culturing of all removed catheters, and only
recommend culturing catheters from patients
when bloodstream infection is suspected.
Although qualitative culture has no role in the
diagnosis of IV-CC [3–5], and should be clearly
discouraged, it was the only method used in
> 11% of European laboratories, most of which
were in non-EU countries. Fortunately, most
laboratories use the recommended techniques,
and in > 23% of EU microbiology laboratories, the
most recent quantitative methods have replaced
Maki’s semiquantitative catheter tip culture.
In parallel, more conservative diagnostic tests,
which do not depend on catheter withdrawal,
have been developed. These include comparative
quantitative blood cultures taken from a catheter
and peripheral veins [6], skin and hub cultures
[7], and differential time of growth between blood
obtained from a catheter and that obtained from
peripheral veins [8]. The wide use of these
techniques reported in the present study (nearly
70%) seems to be proof of the acceptance in
European institutions of conservative diagnostic
techniques for IV-CRI. Nevertheless, it should not
be inferred that these institutions are using such
techniques exclusively on a day-to-day basis.
The aetiology of IV-CRI in Europe, as shown in
the present study, is associated mostly with
Gram-positive microorganisms (coagulase-negat-
ive staphylococci and S. aureus), as reported in
other European studies [9, 10]. Candida spp. is the
third most common pathogen isolated in cases of
IV-CRI, reflecting the reported rising trend of this
microorganism as a major nosocomial pathogen
in developed countries [11–13]. The significance
of the higher incidence of S. aureus in non-EU
countries cannot be explained clearly, although
it may be associated with differences in the
procedures employed in the insertion of intravas-
cular catheters and in operating theatres, as well
as antiseptic measures, etc.
The resistance patterns of the IV-CRI isolates
reported in this study should be considered with
caution for several reasons: the study was not
Table 5. Organisms isolated from
catheter tip samples
EU countries
(n = 132)
Non-EU countries
(n = 36)
Total
(n = 168)
Organism No. (%) Organism No. (%) Organism No. (%)
CONS 68 (51.5%) CONS 14 (40%) CONS 82 (49.1%)
Candida spp.a 12 (9.1) S. aureusb 12 (34.3) S. aureus 20 (11.9)
S. aureusb 8 (6.1) Acinetobacter spp. 2 (5.7) Candida spp. 12 (7.2)
Pseudomonas spp. 7 (5.3) Corynebacterium spp. 2 (5.7) Enterococcus spp. 9 (5.9)
Enterobacter spp. 6 (4.5) Enterococcus spp. 2 (5.7) Pseudomonas spp. 8 (4.9)
Enterococcus spp. 6 (4.5) Enterobacter spp. 1 (2.9) Acinetobacter spp. 7 (4.2)
Acinetobacter spp. 5 (3.8) Klebsiella spp. 1 (2.9) Enterobacter spp. 7 (4.2)
Klebsiella spp. 5 (3.8) Pseudomonas spp. 1 (2.9) Klebsiella spp. 6 (3.6)
Proteus spp. 4 (3) Others 1 (2.9) Proteus spp. 4 (2.4)
E. coli 3 (2.3) Corynebacterium spp. 4 (2.4)
Corynebacterium spp. 2 (1.5) E. coli 3 (1.8)
Others 6 (4.5) Others 6 (3.6)
CONS, coagulase-negative staphylococci.
aSpeciation of Candida isolates was not requested in the questionnaire.
bp < 0.0001.
Table 6. Overall resistance rates in organisms isolated
from catheter tip cultures
Antimicrobial
agents tested
Gram-negative
bacteria
Gram-positive
bacteria
S. aureus CONS
Cefotaxime 13 ⁄ 37 (35%) NT NT NT
Ceftazidime 12 ⁄ 37 (31%) NT NT NT
Cefepime 4 ⁄ 37 (10.8%) NT NT NT
Imipenem 4 ⁄ 37 (10.8%) NT NT NT
Ciprofloxacin 10 ⁄ 37 (27%) NT NT NT
Oxacillin NT 61 ⁄ 118 (51.5%) 8 ⁄ 20 (40%) 52 ⁄ 82 (63.4%)
Vancomycin NT 2 ⁄ 118 (1.7%) 0 1 ⁄ 82 (1.2%)
CONS, coagulase-negative staphylococci; NT, not tested.
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designed to evaluate the resistance rates directly,
the isolates were not tested in a central laboratory,
and only a few microorganisms were studied.
However, some interesting inferences were
drawn from the data in this study. There were
high rates of resistance in Gram-negative isolates
from catheter tips (> 30% to cefotaxime and
ceftazidime, and nearly 30% to ciprofloxacin). A
similar observation was made in a European
study of nosocomial bacteraemia isolates by
Dornbusch et al. [14], in which it was also noted
that countries previously belonging to the ‘eastern
block’ had higher rates of resistance. Another
concern was that 40% of S. aureus isolates from
catheter tips were oxacillin-resistant in the pre-
sent study, which supports the use of glycopep-
tides as first-line empirical antimicrobial agents
for catheter-related bloodstream infections.
In conclusion, the microbiological diagnosis of
IV-CRI is increasingly more effective in European
institutions, but there are still some deficiencies in
the techniques used, especially in non-EU coun-
tries. The recognition of new pathogens such as
Candida spp., and the increasing rates of antibiotic
resistance in Gram-positive and Gram-negative
bacteria, stress the need for a general European
surveillance system.
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